1. A 10-color flow cytometry panel for diagnosis and minimal residual disease in chronic lymphocytic leukemia. Issue 10 (24th August 2021) Authors: Bazinet, Alexandre; Rys, Ryan N.; Barry, Amadou; Greenwood, Celia M. T.; Young, Yoon Kow; Mendoza, Alma; LaPorta, Ida; Wever, Claudia M.; Mercier, François E.; Johnson, Nathalie A. Journal: Leukemia & lymphoma Issue: Volume 62:Issue 10(2021) Page Start: 2352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders. Issue 9 (23rd February 2022) Authors: Tanguay, Mégane; Boutin, Marianne; Laumaea, Annemarie; Salaciak, Matthew; Mendoza, Alma; Cassis, Chantal; Ajjamada, Lissa; Assouline, Sarit; Patenaude, François; Clark, Michael Webster; Finzi, Andrés; Johnson, Nathalie A. Journal: Vaccine Issue: Volume 40:Issue 9(2022) Page Start: 1203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Considerations of Control Conditions Designs in Randomized Controlled Trials of Exercise Interventions for Cancer Survivors. Issue 4 (December 2022) Authors: Tock, Wing Lam; Maheu, Christine; Johnson, Nathalie A. Journal: Canadian journal of nursing research = Issue: Volume 54:Issue 4(2022) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Do Mountain Bikers Know When They Have Had a Concussion and, Do They Know to Stop Riding?. Issue 6 (November 2021) Authors: Clark, Gregory; Johnson, Nathalie A.; Saluja, Sanjeet S.; Correa, José A.; Delaney, J. Scott Journal: Clinical journal of sport medicine Issue: Volume 31:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune profiling of a patient with relapsed HIV-Related and EBV-positive diffuse large B-Cell lymphoma treated with pembrolizumab. Issue 5 (16th April 2022) Authors: Korsos, Victoria; Vallée, Alexis; Rys, Ryan; Probst, Stephan; Dmitrienko, Svetlana; Decaluwe, Hélène; Johnson, Nathalie A. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 5(2022) Page Start: 1256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors. Issue 1 (2nd January 2017) Authors: Dupéré-Richer, Daphné; Kinal, Mena; Pettersson, Filippa; Emond, Audrey; Calvo-Vidal, M. Nieves; Nichol, Jessica N.; Guilbert, Cynthia; Plourde, Dany; Klein Oros, Kathleen; Nielsen, Torsten H.; Ezponda, Teresa; Licht, Jonathan D.; Johnson, Nathalie A.; Assouline, Sarit; Cerchietti, Leandro; Miller... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 1(2017) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis. Issue 4 (20th March 2020) Authors: Zinzani, Pier Luigi; Chen, Robert; Armand, Philippe; Johnson, Nathalie A.; Brice, Pauline; Radford, John; Ribrag, Vincent; Molin, Daniel; Vassilakopoulos, Theodoros P.; Tomita, Akihiro; von Tresckow, Bastian; Shipp, Margaret A.; Lin, Jianxin; Nahar, Akash; Balakumaran, Arun; Moskowitz, Craig H. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 4(2020) Page Start: 950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Successful pregnancy and fetal outcome following previous treatment with pembrolizumab for relapsed Hodgkin's lymphoma. Issue 1 (28th May 2021) Authors: Le‐Nguyen, Alexandre; Rys, Ryan N.; Petrogiannis‐Haliotis, Tina; Johnson, Nathalie A. Journal: Cancer reports Issue: Volume 5:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study. Issue 3 (17th January 2023) Authors: Lasater, Elisabeth A.; Amin, Dhara N.; Bannerji, Rajat; Mali, Raghuveer Singh; Barrett, Kathy; Rys, Ryan N.; Oeh, Jason; Lin, Eva; Sterne‐Weiler, Tim; Ingalla, Ellen Rei; Go, MaryAnn; Yu, Shang‐Fan; Krem, Maxwell M.; Arthur, Chris; Hahn, Uwe; Johnston, Anna; Karur, Vinit; Khan, Nadia; Marlton, Pa... Journal: American journal of hematology Issue: Volume 98:Issue 3(2023) Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples. Issue 9 (2nd September 2018) Authors: Wever, Claudia M.; Geoffrion, Dominique; Grande, Bruno M.; Yu, Stephen; Alcaide, Miguel; Lemaire, Maryse; Riazalhosseini, Yasser; Hébert, Josée; Gavino, Christina; Vinh, Donald C.; Petrogiannis-Haliotis, Tina; Dmitrienko, Svetlana; Mann, Koren K.; Morin, Ryan D.; Johnson, Nathalie A. Journal: Leukemia & lymphoma Issue: Volume 59:Issue 9(2018) Page Start: 2159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗